Recurrent Hypoglycemia and Hypercalcemia As Presenting Features of CD30-Positive Peripheral T-cell Lymphoma, Not Otherwise Specified
4 affiliations
- 1Internal Medicine, American University of the Caribbean School of Medicine, Cupecoy, SXM
- 2Internal Medicine, Universidad Hispanoamericana, San José, CRI
- 3Internal Medicine, Jackson Memorial Hospital, Miami, USA
- 4Flow Cytometry, Jackson Memorial Hospital, Miami, USA
Abstract
Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is an aggressive mature T-cell neoplasm that may present with nonspecific systemic and metabolic abnormalities. A 73-year-old man with type 2 diabetes mellitus presented with progressive weakness, altered mental status, recurrent hypoglycemia, and hypercalcemia, accompanied by acute kidney injury, pancytopenia, diffuse lymphadenopathy, and splenomegaly. A complete critical-sample evaluation during hypoglycemia was unavailable, and the mechanism of the parathyroid hormone (PTH)-independent hypercalcemia could not be established because PTH-related peptide and vitamin D metabolite measurements were unavailable.
Core biopsy of a left axillary lymph node demonstrated a mature CD4-positive T-cell lymphoma with strong diffuse CD30 expression, reduced CD7, negative anaplastic lymphoma kinase and Epstein-Barr virus-encoded RNA studies, and a Ki-67 proliferation index exceeding 90%, supporting PTCL-NOS after exclusion of other supported mature T-cell lymphoma entities. Classification remained limited by the absence of an excisional biopsy and additional molecular studies. Prednisone cytoreduction was followed by cyclophosphamide, doxorubicin, and prednisone, with brentuximab vedotin planned but not documented as administered. The course was complicated by profound myelosuppression, Klebsiella pneumoniae pneumonia, and neutropenic septic shock. Formal response assessment was not possible because complete staging and adequate follow-up were unavailable.
This case highlights the importance of prompt tissue diagnosis when unexplained metabolic abnormalities coexist with cytopenias and generalized lymphadenopathy. Although hypoglycemia and hypercalcemia occurred in association with PTCL-NOS, the available data do not establish a causal or paraneoplastic relationship.
Related
- Ampullary Neuroendocrine Carcinoma Presenting with Clinically Confirmed Endogenous Hyperinsulinemic Hypoglycemia
- Acute Confusion as the Presenting Feature of Hypoglycemia and Lactic Acidosis in an Adult With Known Fructose-1,6-Bisphosphatase Deficiency.
- Systemic Sclerosis Presenting With Long-Standing Peripheral Neuropathy and Delayed Multisystem Manifestations: A Case Report
- 반복되는 혈변으로 발견된 연소성 용종증 증후군 Juvenile Polyposis Syndrome Presenting with Recurrent Hematochezia
- Case Report: Acquired hemophilia A presenting with recurrent arthritis-like joint swelling and musculoskeletal hematomas—a focused literature review
BibTeX
@article{bidgoli2026recurrent,
title = {{Recurrent Hypoglycemia and Hypercalcemia As Presenting Features of CD30-Positive Peripheral T-cell Lymphoma, Not Otherwise Specified}},
author = {Alireza Izadian Bidgoli and Alberto Gomez Usatorres and Hellen Ailette Gomez Usatorres and Alberto Gomez Veliz and Daina Noriega-Toledo},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.117300},
url = {https://europepmc.org/article/PMC/PMC13723190},
note = {CC BY},
}
RIS
TY - JOUR
TI - Recurrent Hypoglycemia and Hypercalcemia As Presenting Features of CD30-Positive Peripheral T-cell Lymphoma, Not Otherwise Specified
AU - Alireza Izadian Bidgoli
AU - Alberto Gomez Usatorres
AU - Hellen Ailette Gomez Usatorres
AU - Alberto Gomez Veliz
AU - Daina Noriega-Toledo
PY - 2026
DA - 2026/10/01
JO - Cureus
DO - 10.7759/cureus.117300
UR - https://europepmc.org/article/PMC/PMC13723190
AB - Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is an aggressive mature T-cell neoplasm that may present with nonspecific systemic and metabolic abnormalities. A 73-year-old man with type 2 diabetes mellitus presented with progressive weakness, altered mental status, recurrent hypoglycemia, and hypercalcemia, accompanied by acute kidney injury, pancytopenia, diffuse lymphadenopathy, and splenomegaly. A complete critical-sample evaluation during hypoglycemia was unavailable, and the mechanism of the parathyroid hormone (PTH)-independent hypercalcemia could not be established because PTH-related peptide and vitamin D metabolite measurements were unavailable. Core biopsy of a left axillary lymph node demonstrated a mature CD4-positive T-cell lymphoma with strong diffuse CD30 expression, reduced CD7, negative anaplastic lymphoma kinase and Epstein-Barr virus-encoded RNA studies, and a Ki-67 proliferation index exceeding 90%, supporting PTCL-NOS after exclusion of other supported mature T-cell lymphoma entities. Classification remained limited by the absence of an excisional biopsy and additional molecular studies. Prednisone cytoreduction was followed by cyclophosphamide, doxorubicin, and prednisone, with brentuximab vedotin planned but not documented as administered. The course was complicated by profound myelosuppression, Klebsiella pneumoniae pneumonia, and neutropenic septic shock. Formal response assessment was not possible because complete staging and adequate follow-up were unavailable. This case highlights the importance of prompt tissue diagnosis when unexplained metabolic abnormalities coexist with cytopenias and generalized lymphadenopathy. Although hypoglycemia and hypercalcemia occurred in association with PTCL-NOS, the available data do not establish a causal or paraneoplastic relationship.
SN - 2168-8184
ER -